Bausch & Lomb Corp Deferred Income Tax Expense (Benefit)
Bausch & Lomb Corp (BLCO) reported Deferred Income Tax Expense (Benefit) of -$35.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-18
- Bausch & Lomb Corp deferred income tax expense (benefit) for fiscal 2025 was -$35.00M.
- Bausch & Lomb Corp deferred income tax expense (benefit) for fiscal 2024 was -$4.00M, a 136.36% decline from fiscal 2023.
- Bausch & Lomb Corp deferred income tax expense (benefit) for fiscal 2023 was $11.00M.
- Bausch & Lomb Corp deferred income tax expense (benefit) for fiscal 2022 was -$13.00M.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$35.00M 10-K · filed 2026-02-18 |
| 2024-12-31 | -$4.00M 10-K · filed 2026-02-18 |
| 2023-12-31 | $11.00M 10-K · filed 2026-02-18 |
| 2022-12-31 | -$13.00M 10-K · filed 2025-02-19 |
| 2021-12-31 | -$74.00M 10-K · filed 2024-02-21 |
| 2020-12-31 | $152.00M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |